Multicell Technologies Inc (MCET)

Currency in USD
0.00010
0.00000(0.00%)
Delayed Data·
Trading near 52-week Low
MCET is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.000100.00010
52 wk Range
0.000100.00050
Key Statistics
Prev. Close
-
Open
0.0001
Day's Range
0.0001-0.0001
52 wk Range
0.0001-0.0005
Volume
10.2K
Average Volume (3m)
492.27K
1-Year Change
-50%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MCET Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Earnings

Latest Release
Jan 29, 2025
EPS / Forecast
-- / --
Revenue / Forecast
194.77K / --
EPS Revisions
Last 90 days

MCET Income Statement

Compare MCET to Peers and Sector

Metrics to compare
MCET
Peers
Sector
Relationship
P/E Ratio
0.0x−1.7x−0.3x
PEG Ratio
0.000.000.00
Price/Book
0.0x1.1x2.6x
Price / LTM Sales
0.0x5.0x2.9x
Upside (Analyst Target)
-198.4%62.2%
Fair Value Upside
Unlock21.9%8.6%Unlock

MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. Its product portfolio comprises MCT-125, a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue; MCT-465, a preclinical synthetic double-stranded RNA (dsRNA) therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers; and MCT-485, a discovery stage dsRNA therapeutic candidate with tumor cytolytic properties for the treatment of various cancers. The company also develops Ideal BioStent, a bioabsorbable stent for interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. has a license agreement with Corning Incorporated and Pfizer Inc. The company was formerly known as Exten Industries, Inc. and changed its name to MultiCell Technologies, Inc. in April 2004. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island.

FAQ

What Is the Multicell Tech (MCET) Stock Price Today?

The Multicell Tech stock price today is 0.00010 USD.

What Stock Exchange Does Multicell Tech Trade On?

Multicell Tech is listed and trades on the OTC Markets.

What Is the Stock Symbol for Multicell Tech?

The stock symbol for Multicell Tech is "MCET."

What Is the Multicell Tech Market Cap?

As of today, Multicell Tech market cap is 500.10000K USD.

From a Technical Analysis Perspective, Is MCET a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Multicell Tech Stock Split?

Multicell Tech has split 2 times.

How Many Employees Does Multicell Tech Have?

Multicell Tech has 2 employees.

What is the current trading status of Multicell Tech (MCET)?

As of Oct 30, 2026, Multicell Tech (MCET) is trading at a price of 0.00010 USD, with a previous close of 0.00000 USD. The stock has fluctuated within a day range of 0.00010 USD to 0.00010 USD, while its 52-week range spans from 0.00010 USD to 0.00050 USD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.